Suppr超能文献

一种新兴的重组人肠道病毒 71 型是导致中国阜阳市 2008 年手足口病爆发的原因。

An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China.

机构信息

Key Laboratory for Molecular Virology & Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

出版信息

Virol J. 2010 May 12;7:94. doi: 10.1186/1743-422X-7-94.

Abstract

Hand, foot and mouth disease (HFMD), a common contagious disease that usually affects children, is normally mild but can have life-threatening manifestations. It can be caused by enteroviruses, particularly Coxsackieviruses and human enterovirus 71 (HEV71) with highly variable clinical manifestations. In the spring of 2008, a large, unprecedented HFMD outbreak in Fuyang city of Anhui province in the central part of southeastern China resulted in a high aggregation of fatal cases. In this study, epidemiologic and clinical investigations, laboratory testing, and genetic analyses were performed to identify the causal pathogen of the outbreak. Of the 6,049 cases reported between 1 March and 9 May of 2008, 3023 (50%) were hospitalized, 353 (5.8%) were severe and 22 (0.36%) were fatal. HEV71 was confirmed as the etiological pathogen of the outbreak. Phylogenetic analyses of entire VP1 capsid protein sequence of 45 Fuyang HEV71 isolates showed that they belong to C4a cluster of the C4 subgenotype. In addition, genetic recombinations were found in the 3D region (RNA-dependent RNA polymerase, a major component of the viral replication complex of the genome) between the Fuyang HEV71 strain and Coxsackievirus A16 (CV-A16), resulting in a recombination virus. In conclusion, an emerging recombinant HEV71 was responsible for the HFMD outbreak in Fuyang City of China, 2008.

摘要

手足口病(HFMD)是一种常见的传染病,通常影响儿童,通常症状轻微,但也可能有危及生命的表现。它可由肠道病毒引起,尤其是柯萨奇病毒和肠道病毒 71 型(HEV71),临床表现高度多变。2008 年春季,中国东南部中部安徽省阜阳市发生了一次大规模、前所未有的手足口病暴发,导致大量致命病例聚集。在这项研究中,进行了流行病学和临床调查、实验室检测和遗传分析,以确定暴发的病原体。在 2008 年 3 月 1 日至 5 月 9 日报告的 6049 例病例中,有 3023 例(50%)住院,353 例(5.8%)为重症,22 例(0.36%)死亡。HEV71 被确认为暴发的病原体。对 45 株阜阳 HEV71 分离株的全长 VP1 衣壳蛋白序列进行的系统进化分析表明,它们属于 C4 亚属 C4a 簇。此外,在阜阳 HEV71 株和柯萨奇病毒 A16(CV-A16)的 3D 区(基因组病毒复制复合物的主要成分 RNA 依赖性 RNA 聚合酶)发现了基因重组,导致重组病毒。总之,一种新出现的重组 HEV71 是导致 2008 年中国阜阳市手足口病暴发的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37c/2885340/5b11d81f9743/1743-422X-7-94-1.jpg

相似文献

3
Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
Int J Infect Dis. 2013 Nov;17(11):e1025-30. doi: 10.1016/j.ijid.2013.04.003. Epub 2013 Jun 18.
4
An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China.
J Clin Virol. 2009 Apr;44(4):262-7. doi: 10.1016/j.jcv.2009.02.002. Epub 2009 Mar 9.

引用本文的文献

1
Global Prevalence of Non-Polio Enteroviruses Pre- and Post COVID-19 Pandemic.
Microorganisms. 2025 Aug 1;13(8):1801. doi: 10.3390/microorganisms13081801.
2
Characteristics of CVA16 B1c strains isolated for the first time in the Heilongjiang Province of China.
Front Microbiol. 2025 Aug 6;16:1634547. doi: 10.3389/fmicb.2025.1634547. eCollection 2025.
3
Development of a novel EV-A71 monoclonal antibody for monitoring vaccine potency.
PLoS Negl Trop Dis. 2025 Jun 3;19(6):e0013127. doi: 10.1371/journal.pntd.0013127. eCollection 2025 Jun.
4
Astrocytes-derived LCN2 triggers EV-A71-induced muscle soreness via accumulating lactate.
Sci Adv. 2025 May 16;11(20):eadt9837. doi: 10.1126/sciadv.adt9837.
5
6
ILC3 Function as a Double-Edged Sword in EV71 Infection.
Viruses. 2025 Jan 27;17(2):184. doi: 10.3390/v17020184.
7
Epidemiological characteristics and prediction model construction of hand, foot and mouth disease in Quzhou City, China, 2005-2023.
Front Public Health. 2024 Dec 18;12:1474855. doi: 10.3389/fpubh.2024.1474855. eCollection 2024.
8
Genotyping and phylogeographic dynamics of coxsackievirus A16.
Heliyon. 2024 Sep 21;10(19):e38248. doi: 10.1016/j.heliyon.2024.e38248. eCollection 2024 Oct 15.
10
Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71.
Virol Sin. 2024 Oct;39(5):812-820. doi: 10.1016/j.virs.2024.09.008. Epub 2024 Sep 19.

本文引用的文献

2
Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007.
Vaccine. 2009 May 21;27(24):3153-8. doi: 10.1016/j.vaccine.2009.03.060. Epub 2009 Apr 10.
3
An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China.
J Clin Virol. 2009 Apr;44(4):262-7. doi: 10.1016/j.jcv.2009.02.002. Epub 2009 Mar 9.
4
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.
Mol Biol Evol. 2007 Aug;24(8):1596-9. doi: 10.1093/molbev/msm092. Epub 2007 May 7.
5
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71.
Pediatr Res. 2006 Oct;60(4):466-71. doi: 10.1203/01.pdr.0000238247.86041.19. Epub 2006 Aug 28.
7
Type I interferons protect mice against enterovirus 71 infection.
J Gen Virol. 2005 Dec;86(Pt 12):3263-3269. doi: 10.1099/vir.0.81195-0.
10
Recombinant human enterovirus 71 in hand, foot and mouth disease patients.
Emerg Infect Dis. 2004 Aug;10(8):1468-70. doi: 10.3201/eid1008.040059.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验